NSETrading Window30 Sept 2026 · 30 Sept 2026, 11:37 am
Trading Window
Beta Drugs Limited · BETA
✦ AI Summary
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
BETA_30092026113733_TRADING_WINDOW.pdf
View document text
BDL/PKL/SEC/2026-27
30th September, 2026
The Manager
Listing Department
National Stock Exchange of India Limited
Exchange Plaza, C-1, Block-G
Bandra Kurla Complex
Bandra East
Mumbai 400051
Script :-BETA
Dear Sir,
Subject: Intimation of Closure of Trading Window
Pursuant to circular of National Stock Exchange of India Limited vide reference No.
NSE/CML/2019/11 dated 2nd April, 2019 on “ Clarification regarding Trading restriction
period” SEBI (Prohibition of Insider Trading) Regulation, 2015 and in terms of the
company’s “Code for Prevention of Insider Trading” we wish to inform you that the
Trading Window for trading in the securities of the company shall remain closed for all
the Directors, Officers, Designated Employees, their immediate relatives and all other
covered under the code from 1st October, 2026 till 48 hours after the declaration of
Unaudited Financial Results for the quarter & half year ended 30th September, 2026.
Kindly take the above information on your record.
Thanking You
Your’s faithfully
For Beta Drugs Ltd.
Rajni Brar
Company Secretary